GB Patent

GB2088717A — A composition for the topical treatment of acne

Assigned to Rorer International Overseas Inc · Expires 1982-06-16 · 44y expired

What this patent protects

A composition for the topical treatment of acne comprises as active ingredients are a micronized peroxide of an organic acid e.g. benzoyl peroxide and lauroyl peroxide erythromycin or a derivative thereof. A two-part composition has the erythromycin compound in one part and the r…

USPTO Abstract

A composition for the topical treatment of acne comprises as active ingredients are a micronized peroxide of an organic acid e.g. benzoyl peroxide and lauroyl peroxide erythromycin or a derivative thereof. A two-part composition has the erythromycin compound in one part and the remaining ingredients in a second part. Also, described is a package having two closable containers, one containing the said erythromycin compound and the other containing the remaining ingredients.

Drugs covered by this patent

Patent Metadata

Patent number
GB2088717A
Jurisdiction
GB
Classification
—
Expires
1982-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Rorer International Overseas Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.